Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α‐glucosidase, α‐amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation

Documenti analoghi

• Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline‐isoxazole‐piperazine conjugates as EGFR‐targeting agents
  di: Mohammad Imtiyaz Ali, et al.
  Pubblicazione: (2024)
• Effect of Sulfonamide Functionalization on the Corrosion Inhibition Efficiency of Chitosan for Carbon Steel in 1.0 m HCl : Experimental and Computational Approaches
  di: Moustafa S. Abusaif, et al.
  Pubblicazione: (2026)
• 2‐Thioxo‐3,4‐dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFRT790M and VEGFR‐2 inhibitors: Design, synthesis, docking, and anticancer evaluations
  di: Mohamed S. A. El‐Gaby, et al.
  Pubblicazione: (2024)
• Single and multiple inhibitors of the biosynthesis of 5‐, 12‐, 15‐lipoxygenase products derived from cinnamyl‐3,4‐dihydroxy‐α‐cyanocinnamate: Synthesis and structure–activity relationship
  di: Mohamed Touaibia, et al.
  Pubblicazione: (2024)
• Design, synthesis, in silico, and in vitro evaluation of novel benzyloxybenzene substituted (S)‐α‐amino amide derivatives as cholinesterases and monoaminoxidases inhibitor
  di: Akın Akıncıoğlu
  Pubblicazione: (2024)